All In MedTech

Device Trial Radar · NCT05836844

Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women

APAS Study: Pragmatic Evaluation of the Performance and Safety of the Anchorsure System® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women. A Post-market Multicentre Prospective Observational Cohort Study.

Last checked: Nov 20, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

May 11, 2023

Primary completion

Oct 1, 2024

Study completion Jun 1, 2028

Sponsor

Lead sponsor
Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University Hospital, Lille; Kremlin-Bicetre Hospital, Paris; Clinique Sainte-Anne, Strasbourg; Centre Hospitalier de La Rochelle
First posted
May 1, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 50 years

Summary

As written by the sponsor on the registry.

Pelvic Organ Prolapse affects 50% of parous women, and apical prolapse is one of the most common types of prolapse. Treatment for apical prolapse ranges from observation, non-surgical treatment or surgical repair. An anchoring device can reduce dissection and operative time and is meant to provide strong fixation whilst minimizing potential postoperative pain by avoiding neurovascular injuries. These potential advantages must be evaluated in terms of performance and safety. This cohort study will be on patients undergoing sacrospinous fixation with the Anchorsure® system with a follow-up of 36 months.

Conditions

  • Prolapse; Female
  • Prolapse Uterovaginal
  • Prolapse; Cervix

Interventions

  • The Anchorsure System®Device

    Sacrospinous ligament fixation performed with the Anchorsure Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful performance after sacrospinous fixation of the Anchorsure System®.Time frame: 12 months after fixation

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • La Rochelle General Hospital

    La Rochelle, France · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.